Overview of COVID-19 Medical Research Study
If you’ve been experiencing mild-to-moderate symptoms of COVID-19*** within the last 2–3 days. You may qualify to participate in a clinical study that is testing the effectiveness of an investigational medication designed to prevent COVID-19 disease from becoming more severe. This is especially important for those who are at higher risk of severe illness because of age or underlying chronic health conditions, such as:
Obesity (BMI over 30)
Congestive heart failure
Chronic obstructive pulmonary disease
55 years of age or older
***COVID-19 symptoms include fever, chills, cough, sore throat, a general feeling of weakness or discomfort, headache, joint or muscle pain, change in smell or taste, vomiting, diarrhea, or shortness of breath during physical activity.
What is COVID-19?
According to the World Health Organization, Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face.
The COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette (for example, by coughing into a flexed elbow).
At this time, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments. WHO will continue to provide updated information as soon as clinical findings become available.
You may be eligible to take part in the study if you:
• Are at least 18 years of age or older
• Must be presenting for testing of SARS CoV-2, or for follow-up clinical evaluation after a positive COVID-19 test result.
You may be compensated for time and travel, up to $100 for completed study visit.
Contact us today to learn more about our current study opportunity. Signup online by completing the contact form below, or email our Clinical Care Coordinator, Shamera Jackson at email@example.com. You can also call us at 803.764.2406 or text us at 803.291.4972.